A lot of effort has gone into finding ways to minimize or eliminate off-target edits. In a recent issue of Nature, ...

A 6-year-old Chinese girl died last year after receiving an experimental gene therapy to correct a non-life-threatening ...

The startup is the first gene editing company to price an IPO in more than two years, though it banked far less than most ...

The procedure uses a technology known as base editing to precisely alter a single DNA letter. Read more at straitstimes.com.

The European Union adopted new legislation on plants obtained through certain new genomic techniques in June 2026. The new ...

WASHINGTON: A six-year-old Chinese girl died last year after receiving an experimental gene-therapy to correct a ...

CHOP is partnering with Abu Dhabi to train scientists from the United Arab Emirates’ capital in its pioneering gene-editing treatments. This marks CHOP’s first overseas partnership specific to ...

Scribe Therapeutics is a Phase 1 clinical-stage biopharma developing in vivo CRISPR gene editing for disease prevention, ...

Apertura Gene Therapy, a biotechnology company developing next-generation AAV capsids for delivering genetic medicines, today announced participation in a consortium selected to receive funding from ...

Cathie Wood of Ark Invest first bought shares of Beam Therapeutics (BEAM 4.14%), a biotech focused on precision genetic ...

Persistence Market Research, a leading management consulting firm, has released this update on the gene editing market. Gene editing technologies enable precise modification of DNA, transforming ...

It has also aggressively invested in gene editing, including its 2025 acquisition of cardiovascular disease gene-editing ...